There was no increase in risk for biliary disease, which includes conditions that affect the gallbladder, the liver and the bile ducts, as its incidence was similar for both types of drugs
The dosing is completely different between the two medications and overdosing on these medications can cause severe side effects
The system boosts GLP-1 production by directly stimulating GLP-1 pathways and optimizing the gut microbiome for short-chain fatty acid production
The EXSCEL (NCT01144338), HARMONY (NCT02465515), REWIND ( NCT01394952), and AMPLITUDE-O (NCT03496298) trials all demonstrated cardioprotection or near misses for exenatide, albiglutide, dulaglutide and efpeglenatide, respectively
Alongside its use for overweight and obesity, studies of the drug focused on treating non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH), a condition where fat builds up in the liver